Skip to main content

Canadian drug companies join forces to produce monkeypox vaccine

Share

Montreal-based biopharmaceutical company PnuVax and Ontario-based drug manufacturer Biolyse Pharma announced Wednesday that they have signed an agreement to mass produce a monkeypox vaccine.

The two companies say they have the capabilities to produce millions of doses nationwide.

The undertaking could add up to 50 employees per company.

Monkeypox is a highly contagious disease that can cause painful lesions.

About 1,000 cases have been reported in Canada to date.

-- This report by The Canadian Press was first published in French on Aug. 10, 2022. 

CTVNews.ca Top Stories

BREAKING

BREAKING Honda to get up to $5B in govt help for EV battery, assembly plants

Honda is set to build an electric vehicle battery plant next to its Alliston, Ont., assembly plant, which it is retooling to produce fully electric vehicles, all part of a $15-billion project that is expected to include up to $5 billion in public money.

Secret $70M Lotto Max winners break their silence

During a special winner celebration near their hometown, Doug and Enid shared the story of how they discovered they were holding a Lotto Max ticket worth $70 million and how they kept this huge secret for so long.

Stay Connected